Evidence mapPaperPMID 36337728Full record

ArticleThe journal of cardiovascular aging2022

Promoting healthy cardiovascular aging: emerging topics.

Zachary S Clayton, Daniel H Craighead, Sanna Darvish, McKinley Coppock, Katelyn R Ludwig, Vienna E Brunt, Douglas R Seals, Matthew J Rossman

Open access · hybridAbstract read
In one paragraph

Article in The journal of cardiovascular aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. X's, Y's, and vascular ties: exploring the role of sex chromosomes in arterial stiffness and vascular aging.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Role of the circulating milieu in age-related arterial dysfunction: a novel ex vivo approach.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  14. Effects of regular exercise on vascular function with aging: Does sex matter?American journal of physiology. Heart and circulatory physiology · 2024
    Review
  15. Article
  16. Nitric Oxide as a Determinant of Human Longevity and Health Span.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zachary S ClaytonDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.ORCID 0000-0003-3878-3533
Daniel H CraigheadDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
Sanna DarvishDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
McKinley CoppockDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
Katelyn R LudwigDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
Vienna E BruntDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.ORCID 0000-0002-1941-7936
Douglas R SealsDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.ORCID 0000-0002-2391-9824
Matthew J RossmanDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA.
University of Colorado Boulder · US

Funding

Role of cellular senescence in cardiovascular agingR01AG055822 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI CAMPISI, JUDITH, MELOV, SIMON · 2018 to 2022
$4.9M
Mitochondrial-targeted antioxidant supplementation for improving vascular endothelial function inpostmenopausal women: comparison with standard-of-care exerciseR01AG066730 · NIA · UNIVERSITY OF COLORADO · PI Matthew J Rossman, DOUGLAS R SEALS · 2021 to 2026
$4.0M
Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exerciseR01AG071506 · NIA · UNIVERSITY OF COLORADO · PI DOUGLAS R SEALS · 2021 to 2026
$3.3M
Translational Studies of Age-Associated Arterial Dysfunction, Western Diet and Aerobic Exercise: Role of the Gut MicrobiomeR01HL134887 · NHLBI · UNIVERSITY OF COLORADO · PI SEALS, DOUGLAS R · 2017 to 2020
$3.1M
Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adultsR01AG061514 · NIA · UNIVERSITY OF COLORADO · PI SEALS, DOUGLAS R · 2019 to 2023
$3.1M
Sodium Nitrite Supplementation for Improving Physiological Function in Patients with Chronic Kidney DiseaseK01DK115524 · NIDDK · UNIVERSITY OF COLORADO · PI ROSSMAN, MATTHEW J · 2018 to 2023
$1.1M
Novel time-efficient inspiratory muscle strength training for lowering systolic blood pressure and improving endothelial, cerebrovascular, and cognitive functionK01HL153326 · NHLBI · UNIVERSITY OF MINNESOTA · PI CRAIGHEAD, DANIEL HARRISON · 2020 to 2024
$899k
Translational Studies of the Short-Chain Fatty Acid Acetate for Improving Age-Associated Arterial DysfunctionR00HL151818 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BRUNT, VIENNA E · 2022 to 2024
$747k
Inspiratory muscle strength training for lowering blood pressure in hypertensive mid-life adultsR21AG061677 · NIA · UNIVERSITY OF COLORADO · PI SEALS, DOUGLAS R · 2019 to 2020
$606k
Translational studies of cellular senescence as a regulator of doxorubicin-mediated arterial dysfunctionK99HL159241 · NHLBI · UNIVERSITY OF COLORADO · PI CLAYTON, ZACHARY S. · 2022 to 2023
$350k
Translational Studies of the Short-Chain Fatty Acid Acetate for Improving Age-Associated Arterial DysfunctionK99HL151818 · NHLBI · UNIVERSITY OF COLORADO · PI BRUNT, VIENNA E · 2021 to 2022
$349k
NHLBI NIH HHS K01 HL153326NHLBI NIH HHS K99 HL151818NHLBI NIH HHS K99 HL159241NHLBI NIH HHS R00 HL151818NHLBI NIH HHS R01 HL134887NIA NIH HHS R01 AG055822NIA NIH HHS R01 AG061514NIA NIH HHS R01 AG066730NIA NIH HHS R01 AG071506NIA NIH HHS R21 AG061677NIDDK NIH HHS K01 DK115524
6 · The paper itself

Abstract

The development of age-related cardiovascular (CV) dysfunction increases the risk of CV disease as well as other chronic age-associated disorders, including chronic kidney disease, and Alzheimer's disease and related dementias. Major manifestations of age-associated CV dysfunction that increase disease risk are vascular dysfunction, primarily vascular endothelial dysfunction and arterial stiffening, and elevated systolic blood pressure. Declines in nitric oxide bioavailability secondary to increased oxidative stress and inflammation are established mechanisms of CV dysfunction with aging. Moreover, fundamental mechanisms of aging, termed the "hallmarks of aging" extend to the CV system and, as such, may be considered "hallmarks of CV aging". These mechanisms represent viable therapeutic targets for treating CV dysfunction with aging. Healthy lifestyle behaviors, such as regular aerobic exercise and certain dietary patterns, are considered "first-line" strategies to prevent and/or treat age-associated CV dysfunction. Despite the well-established benefits of these strategies, many older adults do not meet the recommended guidelines for exercise or consume a healthy diet. Therefore, it is important to establish alternative and/or complementary evidence-based approaches to prevent or reverse age-related CV dysfunction. Targeting fundamental mechanisms of CV aging with interventions such as time-efficient exercise training, food-derived molecules, termed nutraceuticals, or select synthetic pharmacological agents represents a promising approach. In the present review, we will highlight emerging topics in the field of healthy CV aging with a specific focus on how exercise, nutrition/dietary patterns, nutraceuticals and select synthetic pharmacological compounds may promote healthy CV aging, in part, by targeting the hallmarks of CV aging.

Indexed as

arterial stiffnessendothelial functionexerciseHallmarks of aginginflammationnutritionoxidative stress

Identifiers

PMID36337728
PMCPMC9632540
OpenAlexW4289211370

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.